Purpose: To evaluate peripapillary retinal nerve fibre layer (RNFL) thickness, measured by spectral-domain optical coherence tomography (SD-OCT), as a surrogate of visual function in a population of paediatric patients affected by optic pathway glioma (OPG) associated with neurofibromatosis type 1 (NF1). Methods: A total of 38 paediatric patients (66 eyes) affected by MRI-proven OPG were included. Each patient underwent complete ophthalmological examination, including age-appropriate visual acuity (VA) assessment and RNFL analysis by SD-OCT. Visual acuity was classified as normal or pathologic using age-based normative data. Visual acuity was correlated to mean RNFL thickness of the whole peripapillary area and of each single analyzed sector (nasal, superior, temporal, inferior). Results: Visual acuity was normal in 43 (65%) and pathologic in 23 (35%) eyes. Mean parapapillary RNFL thickness of each analyzed sector was significantly lower in eyes with abnormal VA (p < 0.05). The best balanced cut-off value of global RNFL thickness allowing to discriminate between eyes with normal and pathologic VA was 76.25 lm (91%, 76%, 67% and 94% of sensitivity, specificity, positive and negative predicting value, respectively). Considering best balanced cut-off values of other analyzed RNFL sectors, the superior (p = 0.0029) and the inferior (p = 0.0024) sectors reached the higher sensitivity (87% and 87%, respectively) and specificity (81% and 79%, respectively). Conclusion: Retinal nerve fibre layer thickness is directly related to VA in children affected by NF1-related OPG, and should be considered as a potential surrogate marker of VA. Retinal nerve fibre layer thickness cut-off values can be used in paediatric patients to discriminate false-positive results obtained by VA measurement.
Introduction
Optic pathway glioma (OPG) is a relatively rare neoplasm in the general population, but it is a defining and common tumour in patients affected by NF1 (Listernick et al. 2007; Payment et al. 2012; Parrozzani et al. 2013) . Optic pathway glioma is histologically defined as low-grade tumour (WHO grade I pilocytic astrocytoma) and develops in 15-20% of NF1 patients (Listernick et al. 2007 ). Most NF1-related OPG are diagnosed in young children (<5 years of age) and onethird to one-half of these patients develop progressive visual loss (Listernick et al. 2007; Payment et al. 2012) .
Classic diagnostic approaches to detect OPG in NF1 paediatric patients include visual acuity (VA) measurement, optic nerve head evaluation and pupillary reflex tests (Listernick et al. 2007; Parrozzani et al. 2013 ). Decreased VA is considered the most clinically relevant indicator of OPG, whereas serial VA measurement the best method to follow-up affected patients Payment et al. 2012) . Unfortunately, the use of VA as an objective diagnostic or treatment-deciding factor in paediatric patients is problematic, due to the fact that subjects may not be able to complete age-appropriate visual function tests, resulting in a large amount of non-accurate and/or false-positive results (Parrozzani et al. 2013) . Moreover, a large proportion of NF1 children have moderate to severe impairment in one or more areas of cognitive function, further reducing the test compliance and the positive predictive value of VA assessment (Pride et al. 2012) .
The introduction of specific retinal and choroidal imaging techniques, based on the use of spectral domain optical coherence tomography, optical coherence tomography angiography and infrared retinal imaging techniques, is rapidly changing the diagnosis and management of NF1 patients, revealing new promising clinical diagnostic and prognostic signs (Avery et al. 2011 (Avery et al. , 2015 Parrozzani et al. 2015 Parrozzani et al. , 2017 Parrozzani et al. , 2018 Parrozzani & Midena 2016) . Inter alia, the use of SD-OCT to detect peripapillary retinal nerve fibre layer (RNFL) changes secondary to the presence of OPG has been proposed as a new clinical diagnostic test to detect OPG in children affected by NF1, even before visual loss, or in children unable to complete age-appropriate visual function tests (Avery et al. 2011 (Avery et al. , 2015 Parrozzani et al. 2013) . Nevertheless, the presence of OPG does not necessarily imply VA reduction (Avery et al. 2011) . Therefore, the use of RNFL thickness as a surrogate marker for VA may be helpful to discriminate sight threatening versus asymptomatic lesions when young children are unable to co-operate in VA testing. The aim of this study is to evaluate the use of RNFL thickness, measured by SD-OCT, as a surrogate of VA in a population of paediatric patients affected by OPG associated with NF1, and to identify a cut-off value allowing to discriminate between normal and pathologic VA.
Materials and Methods
This was an institutional cross-sectional study with prospective enrolment, compliant with the tenets of the Declaration of Helsinki and approved by the institutional IRB. Patients referred to our departments between January 2012 and April 2016 were consecutively recruited. Informed consent was obtained from each patient and/or paediatric subject's legal guardian. Inclusion criteria were paediatric patients (aged 2-15 years) affected by NF1-related (NIH Consensus Development Conference Statement: neurofibromatosis Bethesda 1987). Optic pathway glioma confirmed by orbital and brain MRI. Exclusion criteria were as follows: lack of cooperation in VA assessment and/or SD-OCT imaging acquisition, history of any other ophthalmologic or neurologic disease that could affect visual function, retinal and optic nerve function or aspect or that could impair adequate fundus visualization, and lack of scans with standard imaging parameters on MRI (including the administration of gadolinium). Optic pathway glioma were classified using the original Dodge classification (Dodge et al. 1958 ).
Visual acuity assessment
Visual acuity assessment was performed in each patient as the first clinical test, by an experienced, masked paediatric ophthalmologist. Lea symbols and Snellen charts were used in patients aged 2-6 years old and 4-16 years old, respectively. Patients aged 4-6 years old underwent both tests, starting with Lea, and were classified following the better-obtained result. Lea and Snellen tests were performed according to previously published protocols (Parrozzani et al. 2013) . If the patient was unco-operative during the visit, breaks were permitted and testing reattempted. Visual acuity result in subjects unable to reliably complete testing or those who remained unco-operative was considered 'uninformative' (according to the operator's personal judgment based on patient collaboration and acquired data) and the patient excluded. Lea results were reported in logarithmic values of the minimum angles of resolution (logMAR; Parrozzani et al. 2013) . Visual acuity measurements by Snellen test were converted into log-MAR using published conversion charts (Cyert et al. 2003; Vision in Preschoolers Study Group 2004; Pan et al. 2009; Parrozzani et al. 2013) . Each VA was classified as normal or pathologic following VA age-based normative data (Pan et al. 2009 ).
RNFL assessment by SD-OCT
SD-OCT (Spectralis; Heidelberg Engineering, Heidelberg, Germany) to assess RNFL thickness was performed as previously described (Parrozzani et al. 2013 ). Briefly, each child underwent RNFL assessment after VA measurement and pupil dilation. During measurement, a quality bar visualizes the signal-to-noise ratio. Score quality ranges from 0 (poor) to 40 (excellent). Scans with a quality score <25 were excluded. Centring of the optic disc was performed manually. At least two highspeed peripapillary RNFL circle scans (circle scan size, 3.5 mm) were obtained. Depending on the quality of the scan and correct scan position around the optic nerve, a single RNFL image was chosen for analysis. Peripapillary RNFL thickness measurements were automatically calculated by SD-OCT software, providing a global average (G) and average thickness for each of four sectors: temporal (T), nasal (N), superior (S) and inferior (I). All scans were reviewed for segmentation errors and image artefacts. Retinal nerve fibre layer analysis results in subjects unable to reliably complete correct image acquisition protocol or those who remained unco-operative was considered 'uninformative', and the patient excluded.
Data analysis
Statistical analyses were performed using the SAS version 9.3 software (SAS Institute, Cary, NC, USA). A p value <0.05 was considered statistically significant. Patients with unilateral OPG could only contribute one study eye for the analysis, as this was the only eye at risk for vision loss. Patients with posterior OPG (gliomas involving the chiasma and/or the postchiasmatic visual pathway) contribute two eyes to the analysis. Spearman correlation coefficient was used to analyze the correlation between VA and RNFL thickness. A ROC (receiving operating characteristic) curve has been calculated to determine the cut-off value of the RNFL thickness between the normal VA group and the abnormal one. The cut-off value performance test indicators (sensibility, specificity, and positive and negative predictive values) were evaluated with the chi-squared test of the area under the ROC curve.
Results
Forty-seven consecutive patients affected by NF1-related OPG underwent VA examination and RNFL analysis using SD-OCT. Of these, nine patients (19%) were excluded because of lack of cooperation in VA assessment. These subjects were significantly younger compared to the overall cohort (p < 0.01). No patient was excluded because of lack of co-operation in SD-OCT imaging acquisition. Thirty-eight consecutive NF1-OPG children (66 eyes) represent the study population. Of these, 10 patients (22%) were affected by unilateral optic nerve gliomas (one study eye), whereas 28 patients (78%) were affected by tumours involving both visual pathways (two study eyes). Eleven patients (29%) were new to the clinic, whereas 27 patients (61%) have had one or more prior VA examination in our clinic. Fifteen patients (39%) had previous chemotherapy for OPG, whereas 23 (61%) patients did not receive previous treatments. Clinical and demographic characteristics are reported in Table 1 . Mean VA of the enroled population was 0.2 AE 0.3 log-MAR (range, 0.0-1.4 logMAR; 95% confidence interval: 0.11-0.26 log-MAR) and the mean global RNFL thickness was 78.7 AE 23.3 lm. No differences were documented between untreated and treated patients in mean VA and RNFL thickness (p > 0.05). Using VA age-based normative data, VA was classified as normal in 43 eyes (65%) and pathologic in 23 (35%) eyes. Mean RNFL thickness of the enroled population for each analyzed sector (G, S, I, N, T) is reported in Table 1 . The mean RNFL thickness of each analyzed sector (G, S, I, N, T) was significantly lower in eyes with abnormal VA (p < 0.05; Table 2 ). Considering the global RNFL thickness, the most sensitive and best balanced cut-off values allowing to discriminate between eyes with normal and pathologic VA were 88.25 and 76.25 lm, respectively. The best balanced cut-off reached 91%, 76% 67% and 94% of sensitivity (SE), specificity (SP), positive (PPV) and negative (NPV) predicting value, respectively. The most sensitive cut-off value reached 100%, 55.8%, 54.8% and 100% of SE, SP, PPV and NPV, respectively. The ROC curve obtained for the global RNFL thickness is reported in Fig. 1 and subtends an area under the curve of 0.86. The best balanced and most sensitive cut-off values of each RNFL analyzed sector are reported in Table 3 .
Considering best balanced cut-off values, the superior and inferior sectors reached the highest SE (87% and 87%, respectively) and SP (81% and 79%, respectively), with a PPV of 71.4% and 69.0%, respectively. The most sensitive cut-off value reached 100% for both SE and NPV in each analyzed sector (S, N, I, T). The ROC curves obtained for the superior, inferior, nasal and temporal sectors are reported in Fig. 2 and subtend an area under the curve of 0.86, 0.87, 0.77 and 0.82, respectively. Graphical correlation between global RNFL thickness and visual acuity is reported in Fig. 3 .
Discussion
Optic pathway glioma is clinically characterized by ophthalmologic changes such as visual impairment, abnormal pupillary reflex, strabismus, altered colour vision perception, optic nerve changes, visual field defects and proptosis (Listernick et al. 2007 ). Evidencebased recommendations suggest that all children with NF1 should undergo periodic ophthalmologic examination, mainly including VA assessment, because decreased VA is considered the most clinically relevant indicator of OPG (Listernick et al. 2007; Payment et al. 2012) . Moreover, reduced VA (based on age-based normative data) is also the most important factor to begin the treatment of OPG (Listernick et al. 2007 ). This study shows that a significant proportion (19%) of children with OPG have relatively poor compliance in VA measurement, most of them are younger than 5 years old, limiting the use of VA as the main diagnostic and deciding factor in children with OPG, as well as the main outcome measure in prospective clinical trials (Avery et al. 2013 ). Parrozzani et al. (2013) have recently reported that RNFL thickness by SD-OCT may be considered superior to VA examination in the clinical diagnosis of OPG in NF1 children, thus suggesting that SD-OCT testing can also be used as a sensitive and repeatable outcome measure for any future clinical trial. Moreover, although the use of SD-OCT may be limited by subject co-operation, it is less limited than VA, requiring only a few seconds of co-operation, mainly when used in dedicated clinical centres by trained technicians (Parrozzani et al. 2013 ). Our results indicate that RNFL thickness measure is feasible in most NF1 children, and its value significantly differs between normal and pathologic VA groups. This suggests that RNFL thickness may be used as a potential surrogate of VA. Recently, Avery et al. (2015) confirmed that a >10% RNFL thickness declining (in one or more quadrants or global average) is highly predictive of new vision loss in patients affected by OPG. The same authors reported that the absence of prospective RNFL thickness reduction in serial re-examinations is highly predictive of stable vision (Avery et al. 2015) . Although this information is useful to clinicians when deciding if a child needs to initiate or defer treatment for the presence of OPG, there are no data if RNFL thickness cut-off value may be predictive of normal or abnormal VA at the time of diagnosis. Although the correlation between RNFL thickness and visual acuity in young patients affected by OPG was expected (like all other optic neuropathies), our results suggest that using RNFL thickness analysis by OCT we can identify patients having normal VA with high sensitivity. Using the best balanced global cut-off value, a sensitivity rate of 91.3% can be achieved, also excluding false-positive results in 94.3% of the cases (NPV). Moreover, the best balanced global cut-off value (76 lm) fully agree with age-based normative data for RNFL thickness in children (91.0 lm, 5th percentile; 83.5 lm, 1st percentile; Yanni et al. 2013) . Therefore, our cutoff value is indirectly confirmed by this comparison with age-based normative data for RNFL thickness in children. Thus, the use of RNFL thickness as a surrogate marker of VA may be helpful when young children are unable to cooperate in VA testing, allowing to discriminate false-positive VA results. Another critical key point is that a large portion of OPG (mainly those secondary to NF1) do not need treatment because of their clinical stability and the absence of VA impairment (Listernick et al. 2007; Avery et al. 2011 Avery et al. , 2015 Payment et al. 2012; Parrozzani et al. 2013; Trevisson et al. 2017) . Therefore, RNFL thickness over the cut-off value could reassure clinicians, patient and parents that the tumour, despite being present, is not causing significant VA reduction at that time, even when reliable VA measure is invaluable. This may allow to defer the treatment until direct evidences of VA impairment secondary to the tumour presence. In 2014, Gu et al. proposed the analysis of macular ganglion cell layer-inner plexiform layer (GCL-IPL) thickness as a clinica marker to G = Global; I = Inferior; N = nasal; RNFL = retinal nerve fibre layer; S = superior; SD = standard deviation; T = temporal; VA = visual acuity. * Spearman correlation coefficients. † Statistically significant. G = global; I = inferior; N = nasal; NPV = negative predictive value; RNFL = retinal nerve fibre layer; PPV = positive predictive value; S = superior; SE = specificity; SP = sensibility; T = temporal.
discriminate between children with and without vision loss (VA or visual field) from OPG (Gu et al. 2014) . These authors reported that decreased GCL-IPL thickness (fifth percentile) can discriminate between children with and without vision loss (VA or visual field loss) from their OPG (Gu et al. 2014) . Therefore, ganglion cell layerinner plexiform layer thickness has been proposed as a surrogate marker of vision in children with OPG. The authors used an acquisition protocol of 6 mm 9 6 mm image area, with 1000 A-scans per 100 B-scans, and to perform this acquisition procedure each children was imaged while sedated before MRI scan (Gu et al. 2014) . Therefore, the need of children sedation for this procedure raises many question on it is real clinical utility (Gu et al. 2014 ). In our study, each patient was imaged without any sedation, and no patient was unco-operative to RNFL image acquisition. Although we believe possible to obtain also macular maps in a relevant percentage of NF1 children (perhaps using faster capture protocols compared to the protocol of Gu et al.) , unfortunately, paediatric normative data for the GCL-IPL are not available. A limit of our study is that one-third of enroled patients were new to the clinic whereas the other two-thirds have had one or more prior VA examination performed in our centre. Thus, because subject experience could affect the patient ability to correctly perform VA testing, this difference may have theoretically biased our analysis. Nevertheless, also the one-third of na€ ıve patients referred to our centre underwent one or more prior VA examination in secondary referral centres, using similar (most often identical) VA testing protocol. Therefore, we can suppose that in our cohort of patients the na€ ıve group had similar experience in VA testing compared to the to the nonna€ ıve group. Although a large, multicentric and longitudinal study is needed to confirm these results, our findings may be potentially helpful when making treatment decisions in children with OPG.
Another possible limitation of this study is that a relevant part (39%) of enroled patients was previously treated by systemic chemotherapy. Indeed, Avery et al. (2011) suggested that chemotherapy itself might be a possible cause of RNFL loss in children with OPG. Nevertheless, no difference was documented between untreated and treated patients as mean VA and RNFL thickness (p > 0.05) are concerned.
Despite the promising results from our current and past SD-OCT studies, we do not still recommend making treatment decisions based solely on SD-OCT results, but to use these data to confirm or not specific clinical suspects. The main clinical pitfall using RNFL thickness as a surrogate of VA is the relatively low PPV of this technique (67% in the best-balanced global cut-off value). This result may be a hindrance in using OCT as a substitute for VA, mainly because children with normal vision may be treated unnecessarily. Therefore, we suggest to use the reported cut-off values mainly to In conclusion, RNFL thickness is directly related to VA in children affected by NF1-related OPG, and should be considered as a potential surrogate marker of VA. Retinal nerve fibre layer thickness cut-off values can be used in paediatric patients to discriminate false-positive results obtained by VA measurement. These data can be obtained without patient sedation in most children.
